The roots of racism in America run so deep they even determine who benefits from life extending clinical trials. This truth guides Dana Dornsife in advocating for equitable access to medical treatment, which should be but is not, a standard of care in our medical system. When Dana’s brother-in-law Mike was diagnosed with pancreatic cancer, she immersed herself in enrolling him in a clinical trial. That experience, which allowed him to live another 19 months, inspired Dana to launch the Lazerex Cancer Institute. She knew that with all the challenges Mike faced, it was exponentially harder for people of color without financial support.  Lazerex is upending the status quo for nonprofits in the cancer care arena. It connects people with all forms of cancer to clinical trials, covers the costs of travel for those without means, and engages stakeholders, from patients to hospital administrators in democratizing outdated government policies and profit-driven insurance systems. Lazerex Cancer Foundation is building a bottom up movement for change with the capacity to move the FDA, state and national legislators, and medical institutions to prioritize racial equity. As Dana shows, problems are only intractable when we allow them to be.